US 11,891,359 B2
Prenylated psilocybin derivatives and methods of using
Jillian M. Hagel, Calgary (CA); Peter J. Facchini, Calgary (CA); and Xue Chen, Calgary (CA)
Assigned to ENVERIC BIOSCIENCES CANADA INC., Calgary (CA)
Filed by ENVERIC BIOSCIENCES CANADA INC., Calgary (CA)
Filed on Sep. 29, 2022, as Appl. No. 17/955,922.
Application 17/955,922 is a continuation of application No. PCT/CA2022/050091, filed on Jan. 21, 2022.
Claims priority of provisional application 63/247,926, filed on Sep. 24, 2021.
Claims priority of provisional application 63/140,322, filed on Jan. 22, 2021.
Prior Publication US 2023/0219888 A1, Jul. 13, 2023
Int. Cl. C07D 209/16 (2006.01)
CPC C07D 209/16 (2013.01) 12 Claims
 
1. A chemical compound or salt thereof having formula (I):

OG Complex Work Unit Chemistry
wherein, R6, is a prenyl group, and wherein R4, R5, and R7 are a hydrogen atom, wherein R1 is a hydrogen atom, and R2 is a hydrogen atom or an alkyl group, and wherein R3a is a hydrogen atom, and R3b is an acyl group and R3c is a hydrogen atom or a carboxy group.